Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma.

Authors
Publication date
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio istituzionale della ricerca - Alma Mater Studiorum Università di Bologna

    redirect
    oaioai:cris.unibo.it:11585/5744
    Last time updated on 03/09/2019